ReviewCurrent cardiology reports2022

PCSK9 Inhibitor Wars: How Does Inclisiran Fit in with Current Monoclonal Antibody Inhibitor Therapy? Considerations for Patient Selection.

Natalie Arnold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.